Imatinib Terminated Phase 2 Trials for Chronic Myelogenous Leukemia (CML) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00415909TALL-104 and Gleevec in Chronic Myelogenous Leukemia Patients